Tag: NeuroPace RNS system

NIH study to utilise NeuroPace RNS system for research on the...

NeuroPace has announced that the company’s RNS  system, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy, will be...

NeuroPace present positive data from studies of the RNS System

NeuroPace has presented long-term clinical results demonstrating that the RNS System for refractory epilepsy significantly reduces seizure frequency in patients, with one in three...

NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy...

NeuroPace has closed a US$74 million round of funding led by the KCK Group and OrbiMed Advisors. This funding provides the resources necessary to...